The global vitamin K2 market size was estimated at USD 421.1 million in 2023 and is projected to grow at a CAGR of 10.8% from 2024 to 2030. Increasing consumer awareness of its health benefits, demographic factors such as an aging population, changing dietary preferences towards functional foods, and ongoing research validating its therapeutic properties are driving factors which is attributed to the growth of the vitamin K2 market.
Vitamin K2 is recognized for its positive effects on bone health, cardiovascular health, and overall well-being. As people become more focused on maintaining good health and preventing chronic diseases, the demand for vitamin K2 supplements is expected to increase.In April 2023, Petrovax Pharm, a leading force in Russia's biotech sector renowned for its innovative immunobiological products and vaccines, introduced SunDevit to the Russian market. This cutting-edge complex, distinguished by its unique combination of vitamins D3 and K2, was specifically designed to enhance the immune system and support the health of muscles, bones, and joints.
The rising rates of osteoporosis and cardiovascular diseases globally are significantly boosting the demand for vitamin K2 products. Vitamin K2 is vital for bone health, as it helps direct calcium to strengthen bones and reduce fracture risks. Additionally, research indicates that vitamin K2 can prevent arterial calcification and lower the risk of heart issues. With an aging population and increasing cases of these conditions, interest in vitamin K2 supplements is growing. According to a study in published In February 2024, highlighted that Vitamin K2 notably reduces weight, abdominal fat, and liver fat in mice on a high-fat diet, marking a significant step in understanding its protective role against non-alcoholic fatty liver disease (NAFLD).
The growth of the vitamin K2 market is further driven by key players expanding their product offerings. Companies are focusing on creating innovative formulations and delivery methods to meet diverse consumer preferences and improve product effectiveness. This includes new forms like capsules, tablets, soft gels, and liquids, as well as combining vitamin K2 with other supplements for specific health benefits. The diversifying their product lines, is anticipated to propel the demand for vitamin K2 in the nutraceutical industry. In January 2021, MENADIONA launched a new Vitamin K2 MK-7 grade for nutraceutical use, adhering to US Pharmacopeia standards for purity. This expansion into Vitamin K2 MK-7 complements their existing Vitamin K2 MK-4 offerings, emphasizing their expertise in Vitamin K chemistry and aiming to broaden their market presence.
Furthermore, government agencies worldwide are increasingly recognizing the importance of promoting preventive healthcare through nutrition and dietary supplements. This has led to favorable regulatory frameworks that encourage innovation and quality assurance in the production of vitamin K2 supplements. Thus, the regulatory support for functional food ingredients like vitamin K2, coupled with ongoing research advancements validating its health benefits, are further propelling the growth of the market. Additionally, scientific studies continue to uncover new therapeutic applications of vitamin K2 beyond bone and heart health, creating opportunities for market expansion. For instance, in October 2023, a study featured in Food & Function revealed that vitamin K supplements significantly regulate Fasting Blood Sugar (FBS) and Insulin Resistance (HOMA-IR) and lower the risk of Type 2 Diabetes Mellitus (T2DM).
This product will be delivered within 1-3 business days.
Vitamin K2 is recognized for its positive effects on bone health, cardiovascular health, and overall well-being. As people become more focused on maintaining good health and preventing chronic diseases, the demand for vitamin K2 supplements is expected to increase.In April 2023, Petrovax Pharm, a leading force in Russia's biotech sector renowned for its innovative immunobiological products and vaccines, introduced SunDevit to the Russian market. This cutting-edge complex, distinguished by its unique combination of vitamins D3 and K2, was specifically designed to enhance the immune system and support the health of muscles, bones, and joints.
The rising rates of osteoporosis and cardiovascular diseases globally are significantly boosting the demand for vitamin K2 products. Vitamin K2 is vital for bone health, as it helps direct calcium to strengthen bones and reduce fracture risks. Additionally, research indicates that vitamin K2 can prevent arterial calcification and lower the risk of heart issues. With an aging population and increasing cases of these conditions, interest in vitamin K2 supplements is growing. According to a study in published In February 2024, highlighted that Vitamin K2 notably reduces weight, abdominal fat, and liver fat in mice on a high-fat diet, marking a significant step in understanding its protective role against non-alcoholic fatty liver disease (NAFLD).
The growth of the vitamin K2 market is further driven by key players expanding their product offerings. Companies are focusing on creating innovative formulations and delivery methods to meet diverse consumer preferences and improve product effectiveness. This includes new forms like capsules, tablets, soft gels, and liquids, as well as combining vitamin K2 with other supplements for specific health benefits. The diversifying their product lines, is anticipated to propel the demand for vitamin K2 in the nutraceutical industry. In January 2021, MENADIONA launched a new Vitamin K2 MK-7 grade for nutraceutical use, adhering to US Pharmacopeia standards for purity. This expansion into Vitamin K2 MK-7 complements their existing Vitamin K2 MK-4 offerings, emphasizing their expertise in Vitamin K chemistry and aiming to broaden their market presence.
Furthermore, government agencies worldwide are increasingly recognizing the importance of promoting preventive healthcare through nutrition and dietary supplements. This has led to favorable regulatory frameworks that encourage innovation and quality assurance in the production of vitamin K2 supplements. Thus, the regulatory support for functional food ingredients like vitamin K2, coupled with ongoing research advancements validating its health benefits, are further propelling the growth of the market. Additionally, scientific studies continue to uncover new therapeutic applications of vitamin K2 beyond bone and heart health, creating opportunities for market expansion. For instance, in October 2023, a study featured in Food & Function revealed that vitamin K supplements significantly regulate Fasting Blood Sugar (FBS) and Insulin Resistance (HOMA-IR) and lower the risk of Type 2 Diabetes Mellitus (T2DM).
Global Vitamin K2 Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the publisher has segmented the global vitamin K2 market report based on product, dosage form, indication, application, distribution channel, and region.- Product Outlook (Revenue, USD Million, 2018 - 2030)
- MK-7
- MK-4
- Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)
- Capsules/Tablets
- Softgels
- Liquid
- Others
- Source Outlook (Revenue, USD Million, 2018 - 2030)
- Natural
- Synthetic
- Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Bone Health
- Heart Health
- Blood Clotting
- Others
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Health Supplements
- Functional Foods and Beverages
- Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Offline
- Pharmacies & Drug Stores
- Hypermarkets/Supermarkets
- Others
- Online
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Vitamin K2 Market Variables, Trends & Scope
Chapter 4. Vitamin K2 Market: Product Estimates & Trend Analysis
Chapter 5. Vitamin K2 Market: Dosage Form Estimates & Trend Analysis
Chapter 6. Vitamin K2 Market: Source Estimates & Trend Analysis
Chapter 7. Vitamin K2 Market: Indication Estimates & Trend Analysis
Chapter 8. Vitamin K2 Market: Application Estimates & Trend Analysis
Chapter 9. Vitamin K2 Market: Distribution Channel Estimates & Trend Analysis
Chapter 10. Vitamin K2 Market: Regional Estimates & Trend Analysis
Chapter 11. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Kappa Bioscience
- Gnosis SpA
- NattoPharma
- Seebio Biotech
- Viridis BioPharma
- Kyowa Hakko Bio Co. Ltd.
- Frutarom
- Geneferm Biotechnology Co. Ltd.
- Vesta Nutra
- NOW Foods
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 120 |
Published | July 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 421.1 Million |
Forecasted Market Value ( USD | $ 856.6 Million |
Compound Annual Growth Rate | 10.8% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |